Given the new hazard classes and criteria for classification, labelling and packaging of substances introduced by Commission Delegated Regulation (EU) 2023/707 [Commission Delegated Regulation (EU) 2023/707 of 19 December 2022 amending Regulation (EC) No 1272/2008 as regards hazard classes and criteria for the classification, labelling and packaging of substances and mixtures (OJ L 93, 31.3.2023, p. 7, ELI: http://data.europa.eu/eli/reg_del/2023/707/oj).], a reference to endocrine disruptors for human health, of Category 1, should be made in Section 10.4.1, point (b) of Annex I to Regulation (EU) 2017/745 in light of the relevance of that hazard class to the types of substances in medical devices.
Recital 13, Regulation (EU) 2025/2457
In forcesince 26 Nov 2025